What Blood Pressure Medicine Has the Least Side Effects?

Angiotensin receptor blockers, commonly called ARBs, consistently show the lowest rates of side effects among the major classes of blood pressure medication. In clinical trials, their adverse-event rates are often indistinguishable from placebo, and they tend to produce fewer complaints than any of the other first-line options. That said, “fewest side effects” is not the same as “best medication for you,” and the picture shifts depending on your age, sex, genetics, and what other conditions you’re managing.

Why ARBs Lead the Pack on Tolerability

The major drug classes prescribed for high blood pressure include ARBs (like losartan, valsartan, and telmisartan), ACE inhibitors (like lisinopril and enalapril), calcium channel blockers (like amlodipine), thiazide diuretics (like hydrochlorothiazide and chlorthalidone), and beta-blockers (like atenolol and metoprolol). Each of these works through a different mechanism, and each carries a different side-effect profile.

ARBs stand out because their side-effect rates in clinical trials have been described as “placebo-like,” and they are well tolerated both on their own and when combined with other blood pressure drugs.¹ Even in studies involving young children, where adverse reactions can be harder to manage, valsartan produced side effects at rates similar to placebo, with drug-related adverse events occurring infrequently.² The fact that these drugs are tolerated well across such different patient groups is part of why they’ve become a go-to choice for treating mild and moderate hypertension.

The ACE Inhibitor Cough Problem

ACE inhibitors work similarly to ARBs in that both target the renin-angiotensin system, and they have comparable blood-pressure-lowering ability. But ACE inhibitors carry one frustrating side effect that ARBs largely avoid: a dry, persistent cough. This isn’t a rare quirk. A systematic review and network meta-analysis found that ACE inhibitors caused cough at roughly three times the rate of ARBs.³

The cough happens because ACE inhibitors block the enzyme that breaks down bradykinin and substance P, causing these chemicals to accumulate in the airways and trigger irritation.⁴ ARBs block angiotensin at the receptor level and don’t interfere with bradykinin breakdown, which is why the cough problem largely disappears when patients switch classes. Beyond cough, ARBs also have a better safety profile when it comes to a rarer but more serious issue: angioedema, a potentially dangerous swelling of the face, lips, or throat.⁵

If you’ve been put on an ACE inhibitor and developed a nagging cough, switching to an ARB is one of the most common moves in blood pressure management. Most people who make that switch find the cough resolves within a few weeks.

Calcium Channel Blockers and Ankle Swelling

Calcium channel blockers, particularly amlodipine, are effective and widely prescribed. Their main side-effect issue is ankle and leg swelling (peripheral edema). In one hospital-based study, about one in six patients taking amlodipine developed pedal edema, and the risk increased substantially with longer duration of use.⁶

The swelling is not caused by fluid retention the way heart failure edema is. Instead, amlodipine relaxes the small arteries that feed the legs, increasing the pressure in tiny capillaries and pushing fluid into surrounding tissue. At higher doses, it also blunts a natural reflex that normally constricts skin blood vessels when you stand up, making the fluid shift worse.⁷ This is why the swelling tends to be worse at the end of the day and in people who spend a lot of time on their feet.

Here is where things get interesting from a treatment-strategy perspective. Adding an ARB or an ACE inhibitor to a calcium channel blocker can counteract much of that swelling. A meta-analysis found that combining a calcium channel blocker with any renin-angiotensin system blocker cut the risk of edema by about 38% compared to using the calcium channel blocker alone. ACE inhibitors were especially effective in this pairing, reducing edema risk by over half.⁸ A study looking specifically at valsartan plus amlodipine found that ankle swelling was clinically evident in 24 patients on amlodipine alone but in only 6 patients when valsartan was added.⁹ So a calcium channel blocker with bothersome swelling doesn’t always mean you need a completely different drug. Sometimes adding a second medication solves both the edema and gets your blood pressure further under control.

Thiazide Diuretics and Metabolic Trade-Offs

Thiazide diuretics are among the oldest blood pressure medications still in routine use, and they clearly reduce death from hypertension. But they come with a distinctive set of metabolic side effects. They can lower potassium levels, raise blood sugar, increase uric acid (which can trigger gout), and nudge cholesterol in unfavorable directions.¹⁰ These metabolic shifts are dose-dependent, meaning they become more pronounced at higher doses.¹¹

For someone who is already borderline diabetic, has gout, or struggles with electrolyte balance, thiazides may create more problems than they solve. On the other hand, at low doses, these metabolic effects are often mild and manageable. A lot depends on whether your doctor is monitoring your blood work regularly and whether you’re taking potassium supplements if needed. Thiazides are not a bad choice in many patients, but they’re less “set it and forget it” than ARBs tend to be.

Beta-Blockers Are Not All the Same

Beta-blockers have a reputation for causing fatigue, cold hands, weight gain, and sometimes sexual dysfunction or depressed mood. But lumping them all together is a mistake, because the class is remarkably varied in how different drugs behave. Some are selective for the heart (cardioselective), some affect receptors throughout the body, and some also relax blood vessels.¹²

Nebivolol is a newer beta-blocker that adds vasodilation (blood vessel relaxation) to its effects, and it performs considerably better on tolerability than older agents like atenolol. In one randomized trial, about 37% of patients on atenolol experienced adverse events compared to roughly 13% on nebivolol, with both drugs achieving similar blood pressure reduction.¹³ A separate double-blind multicentre trial confirmed the same pattern: equivalent blood pressure control, but nebivolol with fewer side effects.¹⁴ If you’ve been told beta-blockers make you feel terrible, it’s worth knowing that your experience on one doesn’t predict your experience on another.

The Low-Dose Combination Strategy

One of the most effective ways to minimize side effects from blood pressure medication is not to search for the single “perfect” drug but to use two or three drugs at low doses instead of one drug at a high dose. Side effects from most blood pressure medications are dose-dependent: double the dose and you roughly double (or more) the side-effect risk, while the added blood-pressure benefit is often modest. An analysis of 354 randomized trials found that low-dose combination treatment increases how well blood pressure is controlled while reducing adverse effects.¹⁵

More recent evidence has continued to support this approach. A study of combinations using three or four blood-pressure-lowering drugs at low doses found that the rate of withdrawals due to adverse events was essentially the same as placebo.¹⁶ The idea might feel counterintuitive: taking more pills to have fewer side effects. But the math works out, because you’re using each drug at a level where it barely nudges side-effect risk, while the blood pressure effects of different classes stack together nicely.

Why You Might Still React Badly to a “Well-Tolerated” Drug

Population-level tolerability data are averages, and averages can be misleading when you’re the individual taking the medication. Genetics play a larger role than most people realize. A large pharmacogenomic study identified 14 genome-wide significant locations in the genome associated with people switching away from ACE inhibitors or calcium channel blockers, presumably because of side effects. Among the findings: a specific variant in the neurotensin receptor gene was linked to a dramatically lower risk of ACE-inhibitor cough, and a variant near a liver enzyme gene (CYP3A4) was associated with people needing to switch off calcium channel blockers.¹⁷ People in the top 10% of genetic risk for ACE-inhibitor cough had about twice the cough risk of people in the middle range.

Sex also matters. Women report a higher rate of ACE-inhibitor cough than men.¹⁸ Genetic studies exploring these differences are still in early stages, but the clinical observation is consistent enough that some prescribers are more likely to start women on an ARB rather than an ACE inhibitor.¹⁹

There is another layer worth understanding: the nocebo effect, where negative expectations themselves produce symptoms. In blood pressure trials, patients receiving placebo pills report many of the same side effects (headaches, dizziness, fatigue) attributed to active medication. This makes it genuinely difficult to tease apart which symptoms are caused by the drug and which are caused by expecting to feel bad on a new pill.²⁰ This doesn’t mean your symptoms aren’t real. It means that if you start a new medication already convinced it will make you feel awful, the odds of feeling awful go up regardless of which drug it is.

Fall Risk in Older Adults

For people over 65, the side-effect question takes on a different dimension: fall risk. Any blood pressure medication can cause dizziness when you stand up too quickly, but in older adults, that dizziness can lead to broken bones, head injuries, and hospital stays. A nationally representative study of older adults found that those on blood pressure medication had a roughly 40% higher risk of serious fall injuries compared to those not taking any antihypertensives, though no single drug class stood out as worse than the others.²¹

The risk is highest right after starting a new blood pressure drug or having a dose increased. A study of new users found a 69% increased risk of injurious falls during the first 45 days of treatment. That early risk spike was seen with thiazides, ACE inhibitors, calcium channel blockers, and beta-blockers, though not with ARBs.²² This is another area where ARBs appear to have an edge: they were the one class not associated with increased early fall risk in that study. For older adults, particularly those who are already unsteady, this data point matters.

Drugs That Are Second-Line for a Reason

Not all blood pressure medications carry equal side-effect burdens, and some have been pushed to second-line status specifically because of tolerability. Centrally acting agents like clonidine and methyldopa lower blood pressure by acting on the brain, but they come with sedation, dry mouth, and a rebound hypertension problem when stopped abruptly. Stopping clonidine suddenly can cause a dangerous spike in heart rate and blood pressure in the majority of patients, with some requiring emergency treatment.²³ Methyldopa’s use has declined dramatically because of bothersome side effects including drowsiness, depression, and liver problems, though it still has a niche role in pregnancy where other options are limited.²⁴

Mineralocorticoid receptor antagonists like spironolactone and eplerenone are useful for resistant hypertension that doesn’t respond to standard drugs. Spironolactone is the more potent of the two but comes with hormonal side effects because it binds to progesterone and androgen receptors in addition to its intended target. This can cause breast tenderness and breast enlargement in men, menstrual irregularities in women, and sexual dysfunction. Eplerenone is more selective and avoids most of these hormonal effects, making it a preferable option for patients who are bothered by spironolactone’s side effects or who have metabolic concerns.²⁵

Drug Interactions That Can Change the Equation

Your blood pressure medication doesn’t exist in isolation. Over-the-counter painkillers, particularly nonsteroidal anti-inflammatory drugs like ibuprofen and naproxen, can interact with blood pressure drugs and blunt their effectiveness or amplify certain side effects.²⁶ NSAIDs cause the body to retain sodium and fluid, which directly opposes what diuretics and other blood pressure drugs are trying to do. They can also raise the risk of kidney problems when combined with ACE inhibitors or ARBs, particularly if you’re also taking a diuretic. Many people reach for ibuprofen without thinking twice, not realizing it can undermine their blood pressure treatment and raise their risk of side effects at the same time.

Alcohol, decongestants containing pseudoephedrine, and certain antidepressants can similarly interact with blood pressure medications. If you’re struggling with side effects and also taking other medications or supplements regularly, those interactions are worth discussing with your prescriber before assuming the blood pressure drug itself is the problem.

When You Take It Can Matter

There is some evidence that the timing of your blood pressure dose affects both how well it works and how you experience its side effects. Researchers studying chronotherapy have found that shifting certain medications from morning to bedtime can improve 24-hour blood pressure patterns, particularly the overnight dip that is associated with lower cardiovascular risk.²⁷ For people who feel dizzy or lightheaded during the day on their medication, bedtime dosing sometimes eases that problem by shifting the drug’s peak effect to hours when you’re lying down. This isn’t a universal fix, and some diuretics taken at night will keep you running to the bathroom, but it’s a low-cost adjustment worth trying before giving up on an otherwise effective drug.

Genetic Testing for Blood Pressure Drug Side Effects

Pharmacogenomic testing, where your DNA is analyzed to predict how you’ll respond to specific medications, is still in its early days for hypertension. A genetic study using UK Biobank data found that a genetic risk score could help predict who is likely to develop cough on ACE inhibitors, and identified specific genetic variants tied to how the body metabolizes calcium channel blockers.¹⁷ A separate study using genetic proxies for drug effects found that non-dihydropyridine calcium channel blockers were associated with a higher risk of diverticulosis, while the more commonly prescribed dihydropyridine type (like amlodipine) was not.²⁸

These findings are promising, but we’re not yet at a point where a simple genetic test can tell your doctor exactly which blood pressure drug will work for you with the fewest side effects. The genetics of both drug efficacy and adverse reactions involve many genes interacting in complex ways, and much of the work remains to be done.¹⁹ For now, the process of finding the right medication is still largely trial and adjustment, guided by your medical history, demographics, and which conditions you’re managing alongside high blood pressure.